Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006324HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10003145HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10022102HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10025984HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10051965HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10052093HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS30025272HIVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS30025273HIVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TCGA Plot Options
Drug Information
GeneFDPS
DrugBank IDDB00630
Drug NameAlendronic acid
Target IDBE0000776
UniProt IDP14324
Regulation Typeinhibitor
PubMed IDs10620343; 11752352; 11160603; 17535895
CitationsBergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G: Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ: Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther. 2001 Feb;296(2):235-42.@@Guo RT, Cao R, Liang PH, Ko TP, Chang TH, Hudock MP, Jeng WY, Chen CK, Zhang Y, Song Y, Kuo CJ, Yin F, Oldfield E, Wang AH: Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10022-7. Epub 2007 May 29.
GroupsApproved
Direct ClassificationBisphosphonates
SMILESNCCCC(O)(P(O)(O)=O)P(O)(O)=O
PathwaysAlendronate Action Pathway
PharmGKBPA448082
ChEMBLCHEMBL870